Optimising Treatment of Elderly Patients with Ovarian Cancer: Improving Their Enrolment in Clinical Trials

By Jeannine Villella  

Drugs & Aging, Vol. 22, Iss. 2, 2005-01 ,pp. : 95-100

Adis International

Access to resources Recommend Favorite

Current treatment for ovarian cancer

By Eltabbakh G.H.   Awtrey C.S.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 109-124

Informa Healthcare

Access to resources Recommend Favorite

Applying Proteomics in Clinical Trials: Assessing the Potential and Practical Limitations in Ovarian Cancer

By Tchabo Nana E.   Liel Meghan S.   Kohn Elise C.  

American Journal of PharmacoGenomics, Vol. 5, Iss. 3, 2005-01 ,pp. : 141-148

Adis International

Access to resources Recommend Favorite

Tuberculosis: Current Treatment, Diagnostics, and Newer Antitubercular Agents in Clinical Trials

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 15, Iss. 1, 2015-03 ,pp. : 32-41

Bentham Science Publishers

Access to resources Recommend Favorite

Intermediate clinical endpoints: A bridge between progression-free survival and overall survival in ovarian cancer trials

By Matulonis Ursula A.   Oza Amit M.   Ho Tony W.   Ledermann Jonathan A.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1737-1746

Blackwell Publishing

Access to resources Recommend Favorite